9.95
Schlusskurs vom Vortag:
$10.12
Offen:
$10.009
24-Stunden-Volumen:
5.36M
Relative Volume:
0.76
Marktkapitalisierung:
$9.53B
Einnahmen:
$10.39B
Nettoeinkommen (Verlust:
$-322.87M
KGV:
-29.34
EPS:
-0.3391
Netto-Cashflow:
$-3.55B
1W Leistung:
-4.97%
1M Leistung:
-13.70%
6M Leistung:
-41.23%
1J Leistung:
-56.34%
Xpeng Inc Adr Stock (XPEV) Company Profile
Firmenname
Xpeng Inc Adr
Sektor
Branche
Telefon
-
Adresse
-
Compare XPEV vs TSLA, TM, GM, RACE, F
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
XPEV
Xpeng Inc Adr
|
9.95 | 9.69B | 10.39B | -322.87M | -3.55B | -0.3391 |
|
TSLA
Tesla Inc
|
357.45 | 1.47T | 103.62B | 3.87B | 5.76B | 1.0763 |
|
TM
Toyota Motor Corp Adr
|
188.30 | 225.40B | 336.35B | 26.43B | 1.19B | 19.57 |
|
GM
General Motors Company
|
80.64 | 72.50B | 184.62B | 2.63B | -97.00M | 2.4792 |
|
RACE
Ferrari Nv
|
398.00 | 72.21B | 8.35B | 1.85B | 1.70B | 10.40 |
|
F
Ford Motor Co
|
12.38 | 50.68B | 189.86B | -6.08B | 9.55B | -1.4073 |
Xpeng Inc Adr Stock (XPEV) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-22 | Herabstufung | BNP Paribas Exane | Neutral → Underperform |
| 2026-03-23 | Herabstufung | Macquarie | Outperform → Neutral |
| 2025-11-18 | Hochstufung | Daiwa Securities | Neutral → Buy |
| 2025-08-18 | Eingeleitet | BNP Paribas Exane | Neutral |
| 2025-06-17 | Hochstufung | Goldman | Neutral → Buy |
| 2025-05-21 | Hochstufung | Macquarie | Neutral → Outperform |
| 2025-03-19 | Herabstufung | Daiwa Securities | Buy → Neutral |
| 2025-03-19 | Hochstufung | Nomura | Neutral → Buy |
| 2025-03-10 | Hochstufung | Citigroup | Neutral → Buy |
| 2025-02-24 | Hochstufung | UBS | Sell → Neutral |
| 2025-02-07 | Herabstufung | Macquarie | Outperform → Neutral |
| 2024-12-05 | Herabstufung | UBS | Neutral → Sell |
| 2024-11-22 | Hochstufung | China Renaissance | Hold → Buy |
| 2024-11-21 | Herabstufung | Goldman | Buy → Neutral |
| 2024-09-05 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2024-08-30 | Hochstufung | Macquarie | Neutral → Outperform |
| 2024-06-25 | Hochstufung | Citigroup | Sell → Neutral |
| 2024-05-23 | Hochstufung | Daiwa Securities | Neutral → Buy |
| 2024-04-15 | Fortgesetzt | Macquarie | Neutral |
| 2023-08-21 | Hochstufung | BofA Securities | Neutral → Buy |
| 2023-08-08 | Hochstufung | CLSA | Outperform → Buy |
| 2023-08-07 | Hochstufung | HSBC Securities | Hold → Buy |
| 2023-07-31 | Herabstufung | UBS | Buy → Neutral |
| 2023-07-27 | Hochstufung | Jefferies | Hold → Buy |
| 2023-07-27 | Hochstufung | Macquarie | Underperform → Outperform |
| 2023-07-21 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2023-07-11 | Eingeleitet | Goldman | Buy |
| 2023-06-30 | Herabstufung | CLSA | Buy → Outperform |
| 2023-05-25 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2023-04-25 | Hochstufung | Jefferies | Underperform → Hold |
| 2023-03-24 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2023-02-24 | Herabstufung | HSBC Securities | Buy → Hold |
| 2023-01-11 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2023-01-06 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-12-14 | Herabstufung | Daiwa Securities | Buy → Sell |
| 2022-11-28 | Herabstufung | Jefferies | Hold → Underperform |
| 2022-11-17 | Hochstufung | UBS | Neutral → Buy |
| 2022-10-28 | Herabstufung | Citigroup | Buy → Sell |
| 2022-08-24 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2022-08-03 | Herabstufung | Macquarie | Outperform → Neutral |
| 2022-07-01 | Herabstufung | Nomura | Buy → Neutral |
| 2022-05-25 | Eingeleitet | Macquarie | Outperform |
| 2022-04-01 | Eingeleitet | HSBC Securities | Buy |
| 2022-03-24 | Eingeleitet | China Renaissance | Buy |
| 2022-03-23 | Eingeleitet | CLSA | Buy |
| 2022-02-08 | Eingeleitet | Barclays | Overweight |
| 2022-01-12 | Eingeleitet | Macquarie | Outperform |
| 2021-10-28 | Eingeleitet | Bernstein | Outperform |
| 2021-05-26 | Eingeleitet | Nomura | Buy |
| 2021-03-09 | Hochstufung | Daiwa Securities | Sell → Buy |
| 2021-01-29 | Eingeleitet | Morgan Stanley | Overweight |
| 2021-01-19 | Eingeleitet | Jefferies | Hold |
| 2020-12-14 | Eingeleitet | Deutsche Bank | Buy |
| 2020-12-03 | Herabstufung | UBS | Buy → Neutral |
| 2020-11-04 | Eingeleitet | Citigroup | Buy |
| 2020-09-25 | Eingeleitet | UBS | Buy |
| 2020-09-22 | Eingeleitet | JP Morgan | Overweight |
| 2020-09-21 | Eingeleitet | BofA Securities | Buy |
Alle ansehen
Xpeng Inc Adr Aktie (XPEV) Neueste Nachrichten
XPeng Inc. (XPEV) stock price, news, quote and history - Yahoo Finance Singapore
XPeng Inc. (XPEV) Stock Price, News, Quote & History - Yahoo! Finance Canada
XPeng Inc. (9868.HK) Stock Price, News, Quote & History - Yahoo! Finance Canada
XPENG (NYSE:XPEV) Reaches New 1-Year LowShould You Sell? - MarketBeat
Tesla's EV Dominance Masks Broad Weakness in Pure-Play Stocks - ChartMill
Li Auto's i9 Launch: Should Investors Buy, Sell, or Hold LI Stock? - TradingView
Xpeng stock rises on plans to license tech to foreign automakers - Investing.com
Why Is XPeng Stock Gaining Thursday? - Benzinga
XPENG Launches Its Next-Gen AI Flagship SUV G9L in China, with Global Launch Set for Oct 12 at the Paris Motor Show - Barchart.com
Tesla, XPeng Build Humanoid Robotics, While New ETF Bets on What Makes Them Move - Benzinga
More stocks hit 52-week lows than highs despite S&P 500 near record, signaling market weakness. - Pluang
XPeng Slides As Hybrids Steal Europe EV Spotlight - TipRanks
XPeng Shares Decline Amid Broader China EV Sector Weakness : 기업주식정보 : JKN - news.jkn.co.kr
XPENG (NYSE:XPEV) Sets New 52-Week LowHere's What Happened - MarketBeat
GNK Holdings slams BARK's board for rejecting $22/share cash offer as stock now trades 58% lower. - Pluang
China A-shares fall on high oil prices, interes... - Pluang
XPEV: XPeng IncADR Latest Stock Price, Analysis, News and Trading Ideas - Stocktwits
XPeng, Inc. Class A (9868) Initiated with a Hold at UBS - The Globe and Mail
EV Profitability Gap Narrows as Pure-Plays and Charging Stocks Improve Margins - ChartMill
XPEV Q2 2026 Earnings: Wider-Than-Expected Loss Sends Shares LowerDebt Analysis Report - dars.gov.et
UBS initiates XPeng stock coverage at neutral on robotics value By Investing.com - Investing.com India
UBS initiates XPeng stock coverage at neutral on robotics value - Investing.com
Wall Street Bulls Look Optimistic About XPeng (XPEV): Should You Buy? - Yahoo Finance
XPEV Jumps In Hong Kong: Xpeng Flips The Switch On Humanoid Robot Mass Production — And Says Margins Could Beat EVs - Stocktwits
Finanzdaten der Xpeng Inc Adr-Aktie (XPEV)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):